RANDAL J KIRK Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RANDAL J KIRK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of RANDAL J KIRK for June 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.97 | 72,753 | 1,234,618 | 3,796,606 | 3.9 M to 3.8 M (-1.88 %) |
| Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.97 | 72,753 | 1,234,618 | 3,796,606 | 3.9 M to 3.8 M (-1.88 %) |
| Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.99 | 76,291 | 1,296,184 | 3,869,359 | 3.9 M to 3.9 M (-1.93 %) |
| Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.99 | 76,291 | 1,296,184 | 3,869,359 | 3.9 M to 3.9 M (-1.93 %) |
| Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.34 | 31,795 | 551,325 | 3,945,650 | 4 M to 3.9 M (-0.80 %) |
| Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.34 | 31,795 | 551,325 | 3,945,650 | 4 M to 3.9 M (-0.80 %) |
| Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.97 | 49,678 | 843,036 | 5,197,602 | 5.2 M to 5.2 M (-0.95 %) |
| Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.97 | 49,678 | 843,036 | 5,197,602 | 5.2 M to 5.2 M (-0.95 %) |
| Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.99 | 52,094 | 885,077 | 5,247,280 | 5.3 M to 5.2 M (-0.98 %) |
| Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.99 | 52,094 | 885,077 | 5,247,280 | 5.3 M to 5.2 M (-0.98 %) |
| Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.34 | 21,710 | 376,451 | 5,299,374 | 5.3 M to 5.3 M (-0.41 %) |
| Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.34 | 21,710 | 376,451 | 5,299,374 | 5.3 M to 5.3 M (-0.41 %) |
| Jun 29 2018 | XON | INTREXON CORP | KIRK RANDAL J | Director | Option Exercise | J | 0.00 | 1,257 | 0 | 127,002 | |
| Jun 29 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Option Exercise | J | 0.00 | 1,257 | 0 | 127,002 | |
| Jun 04 2018 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 16.58 | 12,062 | 199,988 | 14,801,058 | 14.8 M to 14.8 M (+0.08 %) |
| Jun 04 2018 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 16.20 | 49,382 | 799,988 | 1,137,273 | 1.1 M to 1.1 M (+4.54 %) |
| Jun 04 2018 | XON | INTREXON CORP | KIRK RANDAL J | Director | Option Exercise | J | 0.00 | 1,245 | 0 | 125,745 | |
| Jun 04 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Option Exercise | J | 0.00 | 1,245 | 0 | 125,745 |